A carregar...
Phase II Trial of Pyrazoloacridine in Children With Solid Tumors: A Pediatric Oncology Group Phase II Study
PURPOSE: Pyrazoloacridine (PZA), a rationally synthesized deoxyribonucleic acid (DNA) binding agent that preferentially inhibits ribonucleic acid rather than DNA synthesis, is active against hypoxic and noncycling tumor cells and has greater in vitro activity against a broad range of human solid tum...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2000
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4008246/ https://ncbi.nlm.nih.gov/pubmed/11132217 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|